Stockscreener 앱 받기
7.76
0.89%
-0.07
시간 외 거래:
7.58
-0.18
-2.32%
전일 마감가:
$7.83
열려 있는:
$7.83
하루 거래량:
41,629
Relative Volume:
0.53
시가총액:
$447.83M
수익:
$181.68M
순이익/손실:
$20.37M
주가수익비율:
22.20
EPS:
0.3495
순현금흐름:
$17.31M
1주 성능:
-3.96%
1개월 성능:
-5.25%
6개월 성능:
-5.83%
1년 성능:
+14.96%
1일 변동 폭
$7.73
$7.91
1주일 범위
$7.46
$8.00
52주 변동 폭
$6.55
$9.35
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
7.76 | 447.83M | 181.68M | 20.37M | 17.31M | 0.3495 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 개시 | The Benchmark Company | Buy |
| 2024-07-03 | 개시 | Stifel | Buy |
| 2018-02-02 | 개시 | Chardan Capital Markets | Buy |
Kamada Ltd 주식(KMDA)의 최신 뉴스
Kamada Ltd (KMDA-Q) Stock Price and News - The Globe and Mail
Kamada stock launches two biosimilars as portfolio reaches four - AD HOC NEWS
Stifel reiterates Kamada stock Buy rating on biosimilar expansion By Investing.com - Investing.com Nigeria
Two drug launches in Israel expand Kamada (KMDA)'s portfolio as it projects sales through 2030. - Stock Titan
About $20 million to $25 million a year is what Kamada expects its medicines to bring in by 2030. - Stock Titan
No pre-approval inventory costs were booked as assets in 2024–25, Kamada (KMDA) says. - Stock Titan
Significant Move: Ishay Davidi Invests $152K In Kamada Stock Options - Benzinga
Witness A Substantial Acquisition As Uri Botzer Acquires $138K In Kamada Stock Options - Benzinga
Lilach Asher Topilsky At Kamada Secures Company Stock Options: $166K Acquired - Benzinga
Significant Move: Ishay Davidi Invests $162K In Kamada Stock Options - Benzinga
Director At Kamada Acquires Company Stock Options Worth $162K - Benzinga
Strategic Investment: Uri Botzer Boosts Portfolio With $148K In Kamada Stock Options - Benzinga
A special cash dividend prompted option-price adjustments for a Kamada (KMDA) director. - Stock Titan
Kamada (KMDA) director Ishay Davidi's previously reported options carry three adjusted exercise prices. - Stock Titan
A special cash dividend adjusted the exercise prices on Kamada (KMDA) director Uri Botzer’s options. - Stock Titan
Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth - Yahoo Finance
Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth - TradingView
Form 4 KAMADA LTD For: 27 September By Investing.com - Investing.com Nigeria
Form 4 KAMADA LTD For: 26 September By Investing.com - Investing.com Nigeria
Big News: Lilach Payorski Adds $136K In Kamada Stock Options Io Portfolio - Benzinga
Insider Decision Making Waves At Kamada: Boris Gorelik Exercises Options, Realizing $0 - Benzinga
Amir London Makes Strategic Play: Invests $1.80M In Kamada Stock Options - Benzinga
Form 4 KAMADA LTD For: 25 September By Investing.com - Investing.com Canada
A special dividend changed the exercise prices on two stock-option awards for Kamada (KMDA)'s CEO. - Stock Titan
KAMADA LTD (NASDAQ: KMDA) Grants 86,500 Derivative Securities to Director Goldwasser Karnit - Kalkine Media
A dividend changed the exercise prices on options acquired by a Kamada (KMDA) director. - Stock Titan
Kamada (KMDA) HR VP receives two option awards that vest in four annual installments. - Stock Titan
Strategic Move: Eran Nir Acquires Kamada Stock Options Worth $173K - Benzinga
Leon Recanati Seizes Opportunity: Acquires $154K Worth Of Kamada Stock Options - Benzinga
Nir Livneh Executes Major Move: Acquires $171K In Kamada Stock Options - Benzinga
A special cash dividend led Kamada (KMDA) to adjust a VP’s stock option prices to $5.98 and $7.44. - Stock Titan
A cash dividend lowered the exercise prices of options awarded to Kamada (KMDA) counsel Nir Livneh. - Stock Titan
Kamada (KMDA) VP’s option prices were adjusted for a special dividend: $5.98 and $7.44 a share. - Stock Titan
Options for Kamada (KMDA) director Leon Recanati vest 25% a year and expire after 10 years. - Stock Titan
A special dividend changed the exercise prices on Kamada (KMDA) CFO's stock options. - Stock Titan
Dividend-linked option reset for Kamada (KMDA) VP - Stock Titan
Kamada (KMDA) director reports 46,000 options at $6.10–$7.38 - Stock Titan
Kamada (NASDAQ: KMDA) grants director 46,000 options; exercise prices adjusted for dividend - Stock Titan
Stock options for Kamada (NASDAQ: KMDA) VP priced at $5.98 and $7.44 - Stock Titan
Special-dividend-adjusted options for Kamada (KMDA) VP - Stock Titan
Kamada (NASDAQ: KMDA) grants director 37,500 share options - Stock Titan
Three option awards for a Kamada (KMDA) director carry prices from $5.99 to $7.41 per share. - Stock Titan
Kamada Ltd. stock holds gains after recent move in healthcare sector - AD HOC NEWS
Kamada Stock Price Forecast. Should You Buy KMDA? - StockInvest.us
StoneX reiterates Kamada stock buy rating on rabies treatment supply By Investing.com - Investing.com Nigeria
Kamada Ltd. (KMDA) Stock Analysis: A Healthcare Gem With 55.71% Potential Upside - DirectorsTalk Interviews
Kamada Ltd (KMDA) Director David Tsur Sells 22,827 Shares - GuruFocus
Kamada Ltd Director David Tsur Sells 22,827 Shares in September 2026 Transaction - Kalkine Media
Kamada (NASDAQ: KMDA) VP exercises options, uses 7,395 shares to cover costs - Stock Titan
Net option move leaves Kamada (KMDA) legal chief 3,459 shares - Stock Titan
Kamada Ltd (KMDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Kamada Ltd 주식 (KMDA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Livneh Nir | VP, General Counsel |
Sep 14 '26 |
Option Exercise |
5.37 |
10,000 |
53,700 |
10,000 |
| Tsur David | Director |
Sep 14 '26 |
Sale |
8.18 |
22,827 |
186,725 |
407,929 |
| Tsur David | Director |
Sep 09 '26 |
Sale |
8.26 |
175 |
1,446 |
430,756 |
| Tsur David | Director |
Sep 08 '26 |
Sale |
8.26 |
162,760 |
1,344,398 |
430,931 |
| Tsur David | Director |
Sep 07 '26 |
Sale |
8.28 |
14,238 |
117,891 |
593,691 |
| Tsur David | Director |
Sep 02 '26 |
Option Exercise |
6.71 |
49,000 |
328,690 |
634,429 |
| Brenner Yael | VP Quality |
Sep 02 '26 |
Option Exercise |
5.94 |
3,036 |
18,034 |
9,302 |
| Brenner Yael | VP Quality |
Aug 26 '26 |
Option Exercise |
6.25 |
30,000 |
187,500 |
16,266 |
5.30%
자본화:
|
볼륨(24시간):